TELA Bio, Inc. Form 8-K Summary
Business Context and Reporting Period
This Current Report on Form 8-K was filed by TELA Bio, Inc. on June 2, 2022, regarding events occurring on June 1, 2022. The report details the results of the Company's 2022 Annual Meeting of Stockholders, which was conducted virtually. As of the record date of April 7, 2022, there were 14,556,750 outstanding shares of common stock.
Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This report focuses exclusively on corporate governance voting results and does not contain financial performance data.
Material Changes
The primary material event reported is the completion of the 2022 Annual Meeting. The key outcomes include the election of three Class III directors and the ratification of the independent registered public accounting firm.
Guidance, Outlook, and Voting Results
The filing provides no guidance, outlook, management commentary on operations, or discussion of risks and contingencies. The specific voting results were as follows:
- Proposal 1: Election of Class III Directors
- Vince Burgess: Elected with 10,793,819 votes For, 1,115,401 Withheld, and 1,300,784 Broker Non-Votes.
- Federica O'Brien: Elected with 11,129,916 votes For, 779,304 Withheld, and 1,300,784 Broker Non-Votes.
- John Nosenzo: Elected with 11,151,119 votes For, 758,101 Withheld, and 1,300,784 Broker Non-Votes.
- Proposal 2: Ratification of Independent Registered Public Accountants
- KPMG LLP was ratified for the 2022 fiscal year with 13,084,355 votes For, 124,770 votes Against, and 879 Abstentions.
Key Facts for Investor Verification
- Verify the tenure of the newly elected Class III directors (Vince Burgess, Federica O'Brien, and John Nosenzo) until the 2025 Annual Meeting.
- Confirm the appointment of KPMG LLP as the independent auditor for the 2022 fiscal year.
- Note the significant number of Broker Non-Votes (1,300,784) recorded for the director elections.
- Review the definitive proxy statement filed on April 21, 2022, for detailed background on the proposals.